DİNÇEL, A. Et Al. 2003. Caffeine as a probe for the assessment of CYP1A2, CYP2A6, NAT2 and xanthine oxidase activity in Turkish population. Proceeding of the Sixth Congress of the European Association for Clinical Pharacology and Therapeutics , (İstanbul, Turkey).

DİNÇEL, A., YAŞAR, Ü., Babaoğlu, M. Ö., BOZKURT, A., BAŞCI AKDUMAN, N. E., & Kayaalp, o. S., (2003). Caffeine as a probe for the assessment of CYP1A2, CYP2A6, NAT2 and xanthine oxidase activity in Turkish population . Proceeding of the Sixth Congress of the European Association for Clinical Pharacology and Therapeutics, İstanbul, Turkey

DİNÇEL, AYSUN Et Al. "Caffeine as a probe for the assessment of CYP1A2, CYP2A6, NAT2 and xanthine oxidase activity in Turkish population," Proceeding of the Sixth Congress of the European Association for Clinical Pharacology and Therapeutics, İstanbul, Turkey, 2003

DİNÇEL, AYSUN Et Al. "Caffeine as a probe for the assessment of CYP1A2, CYP2A6, NAT2 and xanthine oxidase activity in Turkish population." Proceeding of the Sixth Congress of the European Association for Clinical Pharacology and Therapeutics , İstanbul, Turkey, 2003

DİNÇEL, A. Et Al. (2003) . "Caffeine as a probe for the assessment of CYP1A2, CYP2A6, NAT2 and xanthine oxidase activity in Turkish population." Proceeding of the Sixth Congress of the European Association for Clinical Pharacology and Therapeutics , İstanbul, Turkey.

@conferencepaper{conferencepaper, author={AYSUN DİNÇEL Et Al. }, title={Caffeine as a probe for the assessment of CYP1A2, CYP2A6, NAT2 and xanthine oxidase activity in Turkish population}, congress name={Proceeding of the Sixth Congress of the European Association for Clinical Pharacology and Therapeutics}, city={İstanbul}, country={Turkey}, year={2003}}